CPIX
Cumberland Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$46.52M
P/E Ratio
—
EPS
$-0.19
Beta
-0.33
52W High
$6.26
52W Low
$1.85
50-Day MA
$3.60
200-Day MA
$3.37
Dividend Yield
—
Profit Margin
-6.37%
Forward P/E
50.00
PEG Ratio
1.67
About Cumberland Pharmaceuticals Inc
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company is headquartered in Nashville, Tennessee.
Fundamentals
| Revenue (TTM) | $44.52M |
| Gross Profit (TTM) | $37.85M |
| EBITDA | $1.35M |
| Operating Margin | -10.00% |
| Return on Equity | -12.20% |
| Return on Assets | -2.29% |
| Revenue/Share (TTM) | $3.00 |
| Book Value | $1.66 |
| Price-to-Book | 1.88 |
| Price-to-Sales (TTM) | 1.04 |
| EV/Revenue | 1.022 |
| EV/EBITDA | 15.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 31.10% |
| Shares Outstanding | $14.96M |
| Float | $8.72M |
| % Insiders | 41.67% |
| % Institutions | 19.83% |
Historical Volatility
HV 10-Day
63.48%
HV 20-Day
61.21%
HV 30-Day
95.92%
HV 60-Day
79.37%
HV Rank
56.7%
Volatility is currently contracting
Data last updated: 4/10/2026